Alma Lasers News
8 articles
/PRNewswire/ -- Alma Lasers, a Sisram Medical company and a global leader in energy-based medical and aesthetic solutions, has announced the global launch of...
Alma Lasers, a Sisram Medical company, celebrated its 25th anniversary at the Alma Academy in Thailand, attended by 340 physicians and partners from 34 countries. The event highlighted Almas journey since its establishment in 1999, showcasing its innovative aesthetic platforms and commitment to clinical excellence. CEO Lior Dayan emphasized the companys mission to continue driving innovation and excellence in the aesthetic industry. The summit featured 17 world-class experts discussing various topics, including skin rejuvenation, pigmentation, and hair removal. Almas award-winning products, such as Harmony XL Pro and Soprano Titanium, were also showcased. The event underscored Almas role as a leader in the aesthetic industry, fostering collaboration and innovation.
Partners
Fosun Whetted Our Appetite, Says Alma Lasers CEO
Fosun International Ltd., a Chinese conglomerate, acquired Israeli medical laser company Alma Lasers in 2013. The acquisition has had a growth-positive impact on the company, as Alma Lasers has shown healthy organic growth and is one of the top five global companies in the industry. Fosun has set up a holding company called Sisram Medical for the acquisition, which listed on the Hong Kong Stock Exchange in 2017. Although the valuation of Sisram dropped from $490 million to $225 million, Alma Lasers remains optimistic about its future. Fosun officials recently visited Israel to inaugurate a new Alma-Sisram campus and discuss the companys strategy and future plans. Fosun is looking for growth engines through mergers and acquisitions and aims to leverage its global presence for market expansion.
Acquisition
Alma Lasers announces availability of BeautiFill
Alma Lasers to Debut BeautiFill™ Fat Transfer System
Alma Lasers, Inc. announces the North American debut of BeautiFill, a laser-based system designed to optimize the process of autologous fat transfer for aesthetic contouring. BeautiFill combines laser, suction, and fat processing into one step, allowing physicians to quickly harvest and process high-quality fat for immediate reimplantation. The debut will take place at the Annual Meeting of the American Academy of Dermatology. Autologous fat transfer is a growing trend in aesthetic medicine, and BeautiFill offers physicians a new procedure and revenue stream for their practice.
Customers
Alma Lasers to open direct-to-consumer operation in Israel - Medical Design and Outsourcing
Alma Lasers has completed the acquisition of its Israeli distributor, Nova Medical, in a move to extend its business outreach and establish a direct-to-consumer operation in Israel. The acquisition will give Alma a 60% stake in Nova Medical and help the company maintain a leading position and strengthen brand awareness among consumers. Nova Medicals strong market presence and ability to launch in new product domains make it a desirable long-term partner for Alma. The acquisition is part of Almas strategy to provide energy-based medical and aesthetic solutions in the Israeli market.
AcquisitionPartners
Sisram Medical to raise $200m in Hong Kong IPO
Sisram Medical, formerly Alma Lasers, has submitted a prospectus to the Hong Kong Stock Exchange to raise $140-200 million at a company value of $400-500 million. The offering is expected to help Fosun Pharma reduce its debt. Sisram plans to use the funds to make acquisitions in the medical devices sector. The Chinese government has made it difficult to take money out of the country for such investments. Sisram is a leader in the global medical esthetics market and has shown growth in revenue and profit. The offering is scheduled to close soon, with trading in the share to begin on September 19. Fosun Pharma will hold a 51% stake in Sisram Medical after the offering.
InvestmentPublic Trading
We will invest more into medical aesthetic space in India: Ziv Karni
Alma Lasers, a global company in the medical aesthetic devices industry, is focusing on future investment in India due to the countrys expected economic growth surpassing China in the next 10-15 years. The company already has a strong presence in China with a 25% market share. They entered India in 2004 and have recently opened a direct selling office. The market for their products in India is small but growing rapidly, with revenue targets of over $10 million in the next few years. Alma Lasers plans to introduce new products and categories to achieve double-digit growth. They are considering setting up a manufacturing unit in India to make their products more affordable and reach more customers.
Expand
Shanghai Fosun Acquires Israel-Based Alma Lasers For US$240m - Asian Scientist Magazine
Shanghai Fosun Pharma announced the joint acquisition of Alma Lasers Ltd. for US$240 million. Alma Lasers is an international manufacturer of medical and aesthetic devices and has a significant market share in the global high-end aesthetic devices market. The acquisition will provide Fosun Pharma with a strong platform in the Asian and global business development of medical aesthetic devices, particularly in China. The CEO of Alma Lasers expressed excitement about becoming part of Fosun Pharma and benefiting from their professional experiences. Fosun Pharma is confident in the growth potential of the global aesthetics industry, especially in developing countries like China, Brazil, Russia, and India.
Acquisition
